Germany
Japan
United Kingdom
China
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
.jpg?d=110x100 "User supplied image")
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR102D11
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR094F2
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Tyrosine Hydroxylase (TH) mouse monoclonal antibody, clone LNC1
| Applications | IF, IHC, WB |
| Reactivities | All Species |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-PD-L1 Antibody, clone OR-5E4
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-PD-L1 Antibody, clone OR-5E4
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR102D11
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
Mouse anti-PROM1 (CD133) monoclonal antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal ApoE4 Antibody (4E4)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 479.00
2 Weeks
USD 379.00
In Stock
USD 428.00
In Stock
USD 379.00
In Stock
Rabbit monoclonal anti-ST13 Antibody, clone OTIR191G8
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
TGF beta 1 (TGFB1) mouse monoclonal antibody, clone TB21, Azide Free
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Human, Sheep |
| Conjugation | Unconjugated |
ZCCHC24 mouse monoclonal antibody, clone OTI2E1 (formerly 2E1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 524.00
In Stock
Active filters
Category
-
Antibodies
- Primary Antibodies
Applications
- WB
Clonalities
- Monoclonal
Conjugates
- Unconjugated
Filter by
Target Symbol
- VSNL1 (165)
- ALK (162)
- KLK8 (147)
- TP53 (126)
- CD4 (125)
- MAP2K1 (123)
- CDKN2A (104)
- PGR (101)
- NME1 (100)
- PDCD1 (99)
- ERCC1 (95)
- JUN (92)
- MAP2K3 (90)
- GLI1 (88)
- KRT19 (84)
- CTAG1B (81)
- ERBB2 (79)
- EPCAM (78)
- GADD45G (78)
- NBN (78)
- CTNNB1 (75)
- LIPG (75)
- OTC (75)
- CD274 (74)
- EGFR (73)
- PECAM1 (73)
- ABCB1 (72)
- CD68 (72)
- MSMB (71)
- VIM (70)
- CD5 (69)
- HAVCR2 (69)
- PIK3C2A (66)
- NUMB (64)
- CD99 (63)
- ADIPOQ (61)
- MDM2 (61)
- CFI (60)
- NKX3-1 (60)
- PCNA (60)
- TOP2A (60)
- AFP (59)
- L1CAM (59)
- LGALS3 (59)
- CD80 (57)
- MAPK13 (57)
- MLANA (57)
- UBE2E3 (57)
- CD44 (54)
- KRT20 (54)
- SENP2 (54)
- VWF (54)
- TYMS (52)
- APP (51)
- PNMT (51)
- MDM4 (48)
- MIEN1 (48)
- SERPINB3 (48)
- BRAF (47)
- AKT1 (46)
- PDCD1LG2 (46)
- SYP (46)
- PROCR (45)
- TACC2 (45)
- MLH1 (44)
- NCAM1 (44)
- ALDH1L1 (43)
- BCL2 (43)
- BHLHE41 (42)
- CD27 (42)
- FGF21 (42)
- MGMT (42)
- MKI67 (42)
- PTPRC (42)
- RTRAF (42)
- SPG7 (42)
- SQSTM1 (42)
- UBA52 (42)
- IDO1 (41)
- NKX2-1 (41)
- ABAT (40)
- CD33 (40)
- TG (40)
- AFAP1 (39)
- BCL10 (39)
- CD163 (39)
- CNOT4 (39)
- F13A1 (39)
- FCGR2A (39)
- GFAP (39)
- LGR5 (39)
- LRATD2 (39)
- SLA2 (39)
- SNAI2 (39)
- TNFRSF8 (39)
- TYMP (39)
- BTLA (38)
- CHGA (37)
- FTCD (37)
- IDO2 (37)
Reactivities
- Human (39993)
- Mouse (23528)
- Rat (22511)
- Monkey (2801)
- Dog (2410)
- Bovine (83)
- Hamster (78)
- Rabbit (57)
- Chicken (48)
- Primate (45)
- Porcine (41)
- SARS-CoV-2 (39)
- Canine (27)
- Zebrafish (25)
- Pig (24)
- Sheep (24)
- Xenopus (23)
- Drosophila (19)
- Guinea Pig (19)
- Escherichia coli (16)
- Cow (13)
- Yeast (12)
- Mammalian (11)
- C-term DDK (10)
- Goat (10)
- Adenovirus 2 (9)
- Vertebrates (9)
- Virus (9)
- All Species (8)
- Chimpanzee (8)
- Equine (8)
- Feline (8)
- Adenovirus 5 (7)
- Saccharomyces cerevisiae (7)
- Adenovirus 8 (6)
- C. elegans (6)
- Fish (6)
- Streptococcus Pyogenes (6)
- Adenovirus (5)
- Avian (5)
- Frog (5)
- Ferret (4)
- Fruit fly (4)
- Amphibian (3)
- Beluga (3)
- HIV (3)
- Adenovirus 9 (2)
- Bacteria (2)
- Dengue virus (2)
- Dictyostelium (2)
- Drosophila melanogaster (2)
- Insect (2)
- Plant (2)
- West Nile Virus (2)
- Yellow Fever Virus (2)
- Broad (1)
- Carp (1)
- Chlamydomonas (1)
- Helicobacter pylori (1)
- Horse (1)
- Opossum (1)
- Rhesus Monkey (1)
- Salmonella Typhimurium (1)
- Spinach (1)
- Squirrel (1)
- Trichinella spiralis (1)
- White Fly (1)
Antibody Hosts
Isotypes
- IgG1 (26133)
- IgG2a (6586)
- IgG2b (5847)
- IgG (1013)
- IgG1, kappa (280)
- IgG, kappa (138)
- IgG3 (121)
- IgG2a, kappa (75)
- IgG2b, kappa (56)
- IgM (47)
- IgG1, lambda (12)
- IgM, kappa (12)
- IgG2c (10)
- IgG3, kappa (7)
- IgG2a, lambda (5)
- IgG2b, lambda (4)
- IgA, kappa (1)
- IgG fraction (1)
- IgG1/IgK (1)
- IgG2 (1)
- IgG2, alpha (1)
- IgG2, kappa (1)
- IgG3/IgG1 (1)
- IgG4 (1)
- cocktail (1)
Carrier-free
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (35)
- Phospho-specific (15)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (14)
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (13)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (9)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- Modification (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric hamster (Armenian) antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (1)
- This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Chicken scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Chicken scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (21877)
- Transmembrane (6814)
- Transcription Factors (6345)
- Secreted Protein (3380)
- ES Cell Differentiation/IPS (2981)
- Protein Kinase (2468)
- Protease (1655)
- Stem cell - Pluripotency (1458)
- Adult stem cells (763)
- Nuclear Hormone Receptor (562)
- Embryonic stem cells (509)
- Phosphatase (397)
- Cancer stem cells (345)
- Induced pluripotent stem cells (272)
- Stem cell relevant signaling - DSL/Notch pathway (233)
- P450 (187)
- Stem cell relevant signaling - JAK/STAT signaling pathway (185)
- Ion Channels: Other (176)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (94)
- GPCR (93)
- Stem cell relevant signaling - Wnt Signaling pathway (37)
- Ion Channels: Potassium (29)
- Ion Channels: Transient receptor potential (20)
- Ion Channels: Cys-loop Receptors (18)
- Ion Channels: Sodium (8)
- Ion Channels: Glutamate Receptors (2)
- Ion Channels: Calcium (1)
- Ion Channels: Cyclic nucleotide gated (1)
Pathways
- Metabolic pathways (3724)
- Pathways in cancer (2734)
- MAPK signaling pathway (1811)
- Focal adhesion (1359)
- Prostate cancer (1312)
- Cell adhesion molecules (CAMs) (1179)
- T cell receptor signaling pathway (1155)
- Neurotrophin signaling pathway (1119)
- Colorectal cancer (1114)
- Melanoma (1061)
- Toll-like receptor signaling pathway (1060)
- Cytokine-cytokine receptor interaction (1044)
- Pancreatic cancer (1008)
- Bladder cancer (982)
- Glioma (976)
- ErbB signaling pathway (970)
- Chronic myeloid leukemia (957)
- Cell cycle (926)
- Non-small cell lung cancer (918)
- Endometrial cancer (909)
- Progesterone-mediated oocyte maturation (902)
- Regulation of actin cytoskeleton (877)
- B cell receptor signaling pathway (846)
- Insulin signaling pathway (842)
- Hematopoietic cell lineage (834)
- GnRH signaling pathway (759)
- Fc epsilon RI signaling pathway (753)
- Apoptosis (747)
- Endocytosis (747)
- Jak-STAT signaling pathway (735)
- Renal cell carcinoma (725)
- p53 signaling pathway (692)
- Acute myeloid leukemia (685)
- Wnt signaling pathway (658)
- Natural killer cell mediated cytotoxicity (655)
- Purine metabolism (643)
- Chemokine signaling pathway (636)
- Leukocyte transendothelial migration (636)
- Small cell lung cancer (633)
- VEGF signaling pathway (618)
- Alzheimer's disease (601)
- Thyroid cancer (594)
- Gap junction (578)
- Fc gamma R-mediated phagocytosis (574)
- Amyotrophic lateral sclerosis (ALS) (552)
- Pyrimidine metabolism (551)
- Ubiquitin mediated proteolysis (548)
- Oocyte meiosis (542)
- Huntington's disease (522)
- Adherens junction (517)
- Melanogenesis (473)
- Epithelial cell signaling in Helicobacter pylori infection (472)
- Adipocytokine signaling pathway (449)
- mTOR signaling pathway (420)
- Type II diabetes mellitus (415)
- Long-term depression (398)
- Basal cell carcinoma (395)
- Calcium signaling pathway (389)
- Glycolysis / Gluconeogenesis (382)
- Long-term potentiation (382)
- Complement and coagulation cascades (376)
- Axon guidance (374)
- Primary immunodeficiency (371)
- Tight junction (363)
- Pathogenic Escherichia coli infection (359)
- Antigen processing and presentation (357)
- NOD-like receptor signaling pathway (357)
- Arginine and proline metabolism (348)
- RIG-I-like receptor signaling pathway (344)
- Vascular smooth muscle contraction (343)
- Systemic lupus erythematosus (341)
- Parkinson's disease (337)
- Prion diseases (323)
- Nucleotide excision repair (315)
- Valine (293)
- TGF-beta signaling pathway (287)
- Lysosome (286)
- leucine and isoleucine degradation (286)
- Hedgehog signaling pathway (281)
- Dorso-ventral axis formation (277)
- Viral myocarditis (274)
- Oxidative phosphorylation (266)
- Proteasome (252)
- Type I diabetes mellitus (250)
- Autoimmune thyroid disease (247)
- PPAR signaling pathway (247)
- Cytosolic DNA-sensing pathway (244)
- Tryptophan metabolism (243)
- Glycerolipid metabolism (235)
- Lysine degradation (232)
- RNA degradation (228)
- Allograft rejection (226)
- Propanoate metabolism (221)
- Spliceosome (217)
- Drug metabolism - cytochrome P450 (216)
- Graft-versus-host disease (216)
- Phosphatidylinositol signaling system (215)
- Hypertrophic cardiomyopathy (HCM) (211)
- Pyruvate metabolism (209)
- One carbon pool by folate (208)
- Fatty acid metabolism (206)
- Arachidonic acid metabolism (205)
- Metabolism of xenobiotics by cytochrome P450 (204)
- Dilated cardiomyopathy (199)
- Alanine (196)
- ECM-receptor interaction (196)
- aspartate and glutamate metabolism (196)
- Histidine metabolism (192)
- Inositol phosphate metabolism (192)
- Tyrosine metabolism (192)
- Neuroactive ligand-receptor interaction (182)
- DNA replication (181)
- Mismatch repair (181)
- Glutathione metabolism (178)
- Butanoate metabolism (173)
- Notch signaling pathway (170)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (168)
- Base excision repair (161)
- beta-Alanine metabolism (160)
- Glycine (152)
- serine and threonine metabolism (152)
- Drug metabolism - other enzymes (149)
- Renin-angiotensin system (137)
- Retinol metabolism (136)
- Vibrio cholerae infection (134)
- Fructose and mannose metabolism (126)
- Circadian rhythm - mammal (125)
- Homologous recombination (124)
- Maturity onset diabetes of the young (124)
- ABC transporters (120)
- Amino sugar and nucleotide sugar metabolism (120)
- Starch and sucrose metabolism (119)
- Cysteine and methionine metabolism (118)
- Cardiac muscle contraction (116)
- Linoleic acid metabolism (103)
- SNARE interactions in vesicular transport (98)
- Nicotinate and nicotinamide metabolism (97)
- Pentose phosphate pathway (95)
- Asthma (88)
- Citrate cycle (TCA cycle) (88)
- Terpenoid backbone biosynthesis (86)
- RNA polymerase (85)
- Porphyrin and chlorophyll metabolism (84)
- Glycerophospholipid metabolism (83)
- Sphingolipid metabolism (78)
- Regulation of autophagy (75)
- Aminoacyl-tRNA biosynthesis (74)
- Ribosome (74)
- Folate biosynthesis (73)
- Sulfur metabolism (72)
- Ascorbate and aldarate metabolism (67)
- Galactose metabolism (67)
- Caffeine metabolism (66)
- Fatty acid elongation in mitochondria (66)
- Other glycan degradation (66)
- Nitrogen metabolism (65)
- Methane metabolism (64)
- Primary bile acid biosynthesis (61)
- N-Glycan biosynthesis (60)
- Non-homologous end-joining (56)
- Glyoxylate and dicarboxylate metabolism (51)
- Basal transcription factors (48)
- Phenylalanine metabolism (47)
- Selenoamino acid metabolism (45)
- Synthesis and degradation of ketone bodies (43)
- Ether lipid metabolism (42)
- Thiamine metabolism (42)
- Androgen and estrogen metabolism (40)
- Olfactory transduction (40)
- Cyanoamino acid metabolism (39)
- Limonene and pinene degradation (35)
- Glycosaminoglycan degradation (33)
- Taste transduction (33)
- C21-Steroid hormone metabolism (25)
- Pantothenate and CoA biosynthesis (25)
- Fatty acid biosynthesis (23)
- Biosynthesis of unsaturated fatty acids (22)
- Riboflavin metabolism (19)
- Keratan sulfate biosynthesis (18)
- Pentose and glucuronate interconversions (18)
- Vitamin B6 metabolism (18)
- alpha-Linolenic acid metabolism (18)
- Glycosphingolipid biosynthesis - ganglio series (15)
- Glycosphingolipid biosynthesis - lacto and neolacto series (15)
- Glycosphingolipid biosynthesis - globo series (12)
- leucine and isoleucine biosynthesis (10)
- D-Glutamine and D-glutamate metabolism (9)
- Phenylalanine (9)
- Taurine and hypotaurine metabolism (9)
- tyrosine and tryptophan biosynthesis (9)
- Steroid biosynthesis (7)
- O-Glycan biosynthesis (6)
- Protein export (6)
- Biotin metabolism (3)
- Ubiquinone and other terpenoid-quinone biosynthesis (3)